2016冷泉港亚洲会议-肝病和肝癌：从基础研究到临床应用
2016-03-02 来源:本站 点击次数:7644肝病和肝癌：从基础研究到临床应用
4月25-29日 | 苏州独墅湖会议酒店
http://www.csh-asia.org/2016meetings/Liver.html
http://www.csh-asia.org/2016meetings/Liver.html
科学组委会成员:
冯根生, 美国加州大学圣迭戈分校
王红阳, 中国东方肝胆外科医院/研究所
Jessica Zucman-Rossi, 法国全国保健和医学研究院
会议主题：
1. Liver progenitor cells and tumor-initiating cells
2. Liver injuries, fibrosis and cirrhosis
3. Alcoholic and non-alcoholic fatty liver diseases
4. Translational and clinical studies of liver cancer
5. Genomics and bioinformatics of liver diseases
6. Liver metabolism and metabolic disorders
7. Hepatic inflammation and immunity
1. Liver progenitor cells and tumor-initiating cells
2. Liver injuries, fibrosis and cirrhosis
3. Alcoholic and non-alcoholic fatty liver diseases
4. Translational and clinical studies of liver cancer
5. Genomics and bioinformatics of liver diseases
6. Liver metabolism and metabolic disorders
7. Hepatic inflammation and immunity
主题演讲嘉宾:
Scott Lowe, Memorial Sloan Kettering Cancer Center/HHMI, USA
Abstract title: Tumor Suppressor & Tumor Maintenance Genes
Inder Verma, The Salk Institute, USA
Abstract title: Tumor Suppressor & Tumor Maintenance Genes
Inder Verma, The Salk Institute, USA
特邀演讲嘉宾:
David Brenner, University of California, San Diego, USA
Abstract title: Genetics of liver fibrosis
David Cohen, Brigham and Women's Hospital, USA
Abstract title: Acyl-CoA Thioesterase-Mediated Metabolic Regulation
Sabine Colnot, Institut Cochin, INSERM U1016, FRANCE
Abstract title: Metabolic Reprogramming in Beta-Catemin-Driven Liver Carcinogenesis in Mice
Chantal Desdouets, INSERM U567, FRANCE
Abstract title: Liver polyploidy: Dr Jekyll or Mr Hide?
Gen-Sheng Feng, University of California, San Diego, USA
Abstract title: Cooperating or opposing roles of Pten and Shp2 in hepatocarcinogenesis or leukemogenesis
Eithan Galun, Hadassah Hebrew University Hospital, ISRAEL
Abstract title: Mir 122 is a hepatic-hormone with systemic effects
Ping Gao, University of Science & Techonology of China, CHINA
Abstract title: The regulation of metabolic reprogramming in hepatocellular carcinoma cells
Mathias Heikenwälder, Technische Universitat Munchen, GERMANY
Abstract title: Identification of novel targets to treat NASH and its transition to HCC
Lijian Hui, Institute of Biochemistry and Cell Biology, SIBS, CAS, CHINA
Sophie Lotersztajn, Center for Research on Inflammation, Inserm, France
Shelly Lu, Cedars-Sinai Medical Center, USA
Abstract title: Role of Methionine Adenosyltransferase 1A in Liver Cancer
Tom Lüdde, University Hospital RWTH Aachen, GERMANY
Abstract title: Programmed cell death pathways in liver injury and hepatocarcinogenesis
Atsushi Miyajima, University of Tokyo, JAPAN
Abstract title: Remodeling of the biliary tree during liver regeneration
Kanaga Sabapathy, National Cancer Centre Singapore, SINGAPORE
Robert Schwabe, Columbia University, USA
Young-Joon Surh, Seoul National University, SOUTH KOREA
Hongyang Wang, Eastern Hepatobiliary Hospital/Institute of Shanghai, CHINA
Xiao-Fan Wang, Duke University School of Medicine, USA
Abstract title: Inflammation-dependent IL-18 signaling restricts hepatocellular carcinoma growth by systematic modulation of lymphocyte activity
Xin Wei Wang, National Institute of Health, USA
Abstract title: Integrated Omics Investigation of Tumor Heterogeneity and Drivers in Liver Cancer
Holger Willenbring, University of California San Francisco, USA
Abstract title: Hepatocyte plasticity in liver regeneration and cancer
Lars Zender, University Hospital Tuebingen, Germany
Jessica Zucman-Rossi, INSERM U674, FRANCE
Abstract title: Genetics of liver fibrosis
David Cohen, Brigham and Women's Hospital, USA
Abstract title: Acyl-CoA Thioesterase-Mediated Metabolic Regulation
Sabine Colnot, Institut Cochin, INSERM U1016, FRANCE
Abstract title: Metabolic Reprogramming in Beta-Catemin-Driven Liver Carcinogenesis in Mice
Chantal Desdouets, INSERM U567, FRANCE
Abstract title: Liver polyploidy: Dr Jekyll or Mr Hide?
Gen-Sheng Feng, University of California, San Diego, USA
Abstract title: Cooperating or opposing roles of Pten and Shp2 in hepatocarcinogenesis or leukemogenesis
Eithan Galun, Hadassah Hebrew University Hospital, ISRAEL
Abstract title: Mir 122 is a hepatic-hormone with systemic effects
Ping Gao, University of Science & Techonology of China, CHINA
Abstract title: The regulation of metabolic reprogramming in hepatocellular carcinoma cells
Mathias Heikenwälder, Technische Universitat Munchen, GERMANY
Abstract title: Identification of novel targets to treat NASH and its transition to HCC
Lijian Hui, Institute of Biochemistry and Cell Biology, SIBS, CAS, CHINA
Sophie Lotersztajn, Center for Research on Inflammation, Inserm, France
Shelly Lu, Cedars-Sinai Medical Center, USA
Abstract title: Role of Methionine Adenosyltransferase 1A in Liver Cancer
Tom Lüdde, University Hospital RWTH Aachen, GERMANY
Abstract title: Programmed cell death pathways in liver injury and hepatocarcinogenesis
Atsushi Miyajima, University of Tokyo, JAPAN
Abstract title: Remodeling of the biliary tree during liver regeneration
Kanaga Sabapathy, National Cancer Centre Singapore, SINGAPORE
Robert Schwabe, Columbia University, USA
Young-Joon Surh, Seoul National University, SOUTH KOREA
Hongyang Wang, Eastern Hepatobiliary Hospital/Institute of Shanghai, CHINA
Xiao-Fan Wang, Duke University School of Medicine, USA
Abstract title: Inflammation-dependent IL-18 signaling restricts hepatocellular carcinoma growth by systematic modulation of lymphocyte activity
Xin Wei Wang, National Institute of Health, USA
Abstract title: Integrated Omics Investigation of Tumor Heterogeneity and Drivers in Liver Cancer
Holger Willenbring, University of California San Francisco, USA
Abstract title: Hepatocyte plasticity in liver regeneration and cancer
Lars Zender, University Hospital Tuebingen, Germany
Jessica Zucman-Rossi, INSERM U674, FRANCE
|
|
联系方式： Cold Spring Harbor Asia No.299 Qiyue Road, SIP/ Suzhou, Jiangsu Province, China Tel: +86-512-62729029-1301 Fax: +86-512-62729028 Email: mikeji@csh-asia.org Website: www.csh-asia.org |
相关资讯
更多 >